Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Opioid Use Disorder market report explains the definition, types, applications, major countries, and major players of the Opioid Use Disorder market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
Alkermes
Omeros
Orexo
Titan Pharmaceuticals
MediciNova
Teva Pharmaceuticals
Hikma Pharmaceuticals
Camurus
Indivior
By Type:
Buprenorphine
Methadone
Naltrexone
By End-User:
Moderate Pain Treatment
Severe Pain Treatment
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Opioid Use Disorder Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Opioid Use Disorder Outlook to 2028- Original Forecasts
-
2.2 Opioid Use Disorder Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Opioid Use Disorder Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Opioid Use Disorder Market- Recent Developments
-
6.1 Opioid Use Disorder Market News and Developments
-
6.2 Opioid Use Disorder Market Deals Landscape
7 Opioid Use Disorder Raw Materials and Cost Structure Analysis
-
7.1 Opioid Use Disorder Key Raw Materials
-
7.2 Opioid Use Disorder Price Trend of Key Raw Materials
-
7.3 Opioid Use Disorder Key Suppliers of Raw Materials
-
7.4 Opioid Use Disorder Market Concentration Rate of Raw Materials
-
7.5 Opioid Use Disorder Cost Structure Analysis
-
7.5.1 Opioid Use Disorder Raw Materials Analysis
-
7.5.2 Opioid Use Disorder Labor Cost Analysis
-
7.5.3 Opioid Use Disorder Manufacturing Expenses Analysis
8 Global Opioid Use Disorder Import and Export Analysis (Top 10 Countries)
-
8.1 Global Opioid Use Disorder Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Opioid Use Disorder Export by Region (Top 10 Countries) (2017-2028)
9 Global Opioid Use Disorder Market Outlook by Types and Applications to 2022
-
9.1 Global Opioid Use Disorder Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Buprenorphine Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Methadone Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Naltrexone Consumption and Growth Rate (2017-2022)
-
9.2 Global Opioid Use Disorder Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Moderate Pain Treatment Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Severe Pain Treatment Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Opioid Use Disorder Market Analysis and Outlook till 2022
-
10.1 Global Opioid Use Disorder Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Opioid Use Disorder Consumption (2017-2022)
-
10.2.2 Canada Opioid Use Disorder Consumption (2017-2022)
-
10.2.3 Mexico Opioid Use Disorder Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Opioid Use Disorder Consumption (2017-2022)
-
10.3.2 UK Opioid Use Disorder Consumption (2017-2022)
-
10.3.3 Spain Opioid Use Disorder Consumption (2017-2022)
-
10.3.4 Belgium Opioid Use Disorder Consumption (2017-2022)
-
10.3.5 France Opioid Use Disorder Consumption (2017-2022)
-
10.3.6 Italy Opioid Use Disorder Consumption (2017-2022)
-
10.3.7 Denmark Opioid Use Disorder Consumption (2017-2022)
-
10.3.8 Finland Opioid Use Disorder Consumption (2017-2022)
-
10.3.9 Norway Opioid Use Disorder Consumption (2017-2022)
-
10.3.10 Sweden Opioid Use Disorder Consumption (2017-2022)
-
10.3.11 Poland Opioid Use Disorder Consumption (2017-2022)
-
10.3.12 Russia Opioid Use Disorder Consumption (2017-2022)
-
10.3.13 Turkey Opioid Use Disorder Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Opioid Use Disorder Consumption (2017-2022)
-
10.4.2 Japan Opioid Use Disorder Consumption (2017-2022)
-
10.4.3 India Opioid Use Disorder Consumption (2017-2022)
-
10.4.4 South Korea Opioid Use Disorder Consumption (2017-2022)
-
10.4.5 Pakistan Opioid Use Disorder Consumption (2017-2022)
-
10.4.6 Bangladesh Opioid Use Disorder Consumption (2017-2022)
-
10.4.7 Indonesia Opioid Use Disorder Consumption (2017-2022)
-
10.4.8 Thailand Opioid Use Disorder Consumption (2017-2022)
-
10.4.9 Singapore Opioid Use Disorder Consumption (2017-2022)
-
10.4.10 Malaysia Opioid Use Disorder Consumption (2017-2022)
-
10.4.11 Philippines Opioid Use Disorder Consumption (2017-2022)
-
10.4.12 Vietnam Opioid Use Disorder Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Opioid Use Disorder Consumption (2017-2022)
-
10.5.2 Colombia Opioid Use Disorder Consumption (2017-2022)
-
10.5.3 Chile Opioid Use Disorder Consumption (2017-2022)
-
10.5.4 Argentina Opioid Use Disorder Consumption (2017-2022)
-
10.5.5 Venezuela Opioid Use Disorder Consumption (2017-2022)
-
10.5.6 Peru Opioid Use Disorder Consumption (2017-2022)
-
10.5.7 Puerto Rico Opioid Use Disorder Consumption (2017-2022)
-
10.5.8 Ecuador Opioid Use Disorder Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Opioid Use Disorder Consumption (2017-2022)
-
10.6.2 Kuwait Opioid Use Disorder Consumption (2017-2022)
-
10.6.3 Oman Opioid Use Disorder Consumption (2017-2022)
-
10.6.4 Qatar Opioid Use Disorder Consumption (2017-2022)
-
10.6.5 Saudi Arabia Opioid Use Disorder Consumption (2017-2022)
-
10.6.6 United Arab Emirates Opioid Use Disorder Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Opioid Use Disorder Consumption (2017-2022)
-
10.7.2 South Africa Opioid Use Disorder Consumption (2017-2022)
-
10.7.3 Egypt Opioid Use Disorder Consumption (2017-2022)
-
10.7.4 Algeria Opioid Use Disorder Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Opioid Use Disorder Consumption (2017-2022)
-
10.8.2 New Zealand Opioid Use Disorder Consumption (2017-2022)
11 Global Opioid Use Disorder Competitive Analysis
-
11.1 Alkermes
-
11.1.1 Alkermes Company Details
-
11.1.2 Alkermes Opioid Use Disorder Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 Alkermes Opioid Use Disorder Main Business and Markets Served
-
11.1.4 Alkermes Opioid Use Disorder Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 Omeros
-
11.2.1 Omeros Company Details
-
11.2.2 Omeros Opioid Use Disorder Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 Omeros Opioid Use Disorder Main Business and Markets Served
-
11.2.4 Omeros Opioid Use Disorder Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 Orexo
-
11.3.1 Orexo Company Details
-
11.3.2 Orexo Opioid Use Disorder Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 Orexo Opioid Use Disorder Main Business and Markets Served
-
11.3.4 Orexo Opioid Use Disorder Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 Titan Pharmaceuticals
-
11.4.1 Titan Pharmaceuticals Company Details
-
11.4.2 Titan Pharmaceuticals Opioid Use Disorder Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 Titan Pharmaceuticals Opioid Use Disorder Main Business and Markets Served
-
11.4.4 Titan Pharmaceuticals Opioid Use Disorder Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 MediciNova
-
11.5.1 MediciNova Company Details
-
11.5.2 MediciNova Opioid Use Disorder Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 MediciNova Opioid Use Disorder Main Business and Markets Served
-
11.5.4 MediciNova Opioid Use Disorder Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 Teva Pharmaceuticals
-
11.6.1 Teva Pharmaceuticals Company Details
-
11.6.2 Teva Pharmaceuticals Opioid Use Disorder Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 Teva Pharmaceuticals Opioid Use Disorder Main Business and Markets Served
-
11.6.4 Teva Pharmaceuticals Opioid Use Disorder Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 Hikma Pharmaceuticals
-
11.7.1 Hikma Pharmaceuticals Company Details
-
11.7.2 Hikma Pharmaceuticals Opioid Use Disorder Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 Hikma Pharmaceuticals Opioid Use Disorder Main Business and Markets Served
-
11.7.4 Hikma Pharmaceuticals Opioid Use Disorder Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 Camurus
-
11.8.1 Camurus Company Details
-
11.8.2 Camurus Opioid Use Disorder Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 Camurus Opioid Use Disorder Main Business and Markets Served
-
11.8.4 Camurus Opioid Use Disorder Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 Indivior
-
11.9.1 Indivior Company Details
-
11.9.2 Indivior Opioid Use Disorder Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 Indivior Opioid Use Disorder Main Business and Markets Served
-
11.9.4 Indivior Opioid Use Disorder Product Portfolio
-
11.9.5 Recent Research and Development Strategies
12 Global Opioid Use Disorder Market Outlook by Types and Applications to 2028
-
12.1 Global Opioid Use Disorder Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global Buprenorphine Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global Methadone Consumption Forecast and Growth Rate (2022-2028)
-
12.1.3 Global Naltrexone Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Opioid Use Disorder Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Moderate Pain Treatment Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Severe Pain Treatment Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Opioid Use Disorder Market Analysis and Outlook to 2028
-
13.1 Global Opioid Use Disorder Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Opioid Use Disorder Consumption Forecast (2022-2028)
-
13.2.2 Canada Opioid Use Disorder Consumption Forecast (2022-2028)
-
13.2.3 Mexico Opioid Use Disorder Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Opioid Use Disorder Consumption Forecast (2022-2028)
-
13.3.2 UK Opioid Use Disorder Consumption Forecast (2022-2028)
-
13.3.3 Spain Opioid Use Disorder Consumption Forecast (2022-2028)
-
13.3.4 Belgium Opioid Use Disorder Consumption Forecast (2022-2028)
-
13.3.5 France Opioid Use Disorder Consumption Forecast (2022-2028)
-
13.3.6 Italy Opioid Use Disorder Consumption Forecast (2022-2028)
-
13.3.7 Denmark Opioid Use Disorder Consumption Forecast (2022-2028)
-
13.3.8 Finland Opioid Use Disorder Consumption Forecast (2022-2028)
-
13.3.9 Norway Opioid Use Disorder Consumption Forecast (2022-2028)
-
13.3.10 Sweden Opioid Use Disorder Consumption Forecast (2022-2028)
-
13.3.11 Poland Opioid Use Disorder Consumption Forecast (2022-2028)
-
13.3.12 Russia Opioid Use Disorder Consumption Forecast (2022-2028)
-
13.3.13 Turkey Opioid Use Disorder Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Opioid Use Disorder Consumption Forecast (2022-2028)
-
13.4.2 Japan Opioid Use Disorder Consumption Forecast (2022-2028)
-
13.4.3 India Opioid Use Disorder Consumption Forecast (2022-2028)
-
13.4.4 South Korea Opioid Use Disorder Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Opioid Use Disorder Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Opioid Use Disorder Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Opioid Use Disorder Consumption Forecast (2022-2028)
-
13.4.8 Thailand Opioid Use Disorder Consumption Forecast (2022-2028)
-
13.4.9 Singapore Opioid Use Disorder Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Opioid Use Disorder Consumption Forecast (2022-2028)
-
13.4.11 Philippines Opioid Use Disorder Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Opioid Use Disorder Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Opioid Use Disorder Consumption Forecast (2022-2028)
-
13.5.2 Colombia Opioid Use Disorder Consumption Forecast (2022-2028)
-
13.5.3 Chile Opioid Use Disorder Consumption Forecast (2022-2028)
-
13.5.4 Argentina Opioid Use Disorder Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Opioid Use Disorder Consumption Forecast (2022-2028)
-
13.5.6 Peru Opioid Use Disorder Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Opioid Use Disorder Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Opioid Use Disorder Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Opioid Use Disorder Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Opioid Use Disorder Consumption Forecast (2022-2028)
-
13.6.3 Oman Opioid Use Disorder Consumption Forecast (2022-2028)
-
13.6.4 Qatar Opioid Use Disorder Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Opioid Use Disorder Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Opioid Use Disorder Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Opioid Use Disorder Consumption Forecast (2022-2028)
-
13.7.2 South Africa Opioid Use Disorder Consumption Forecast (2022-2028)
-
13.7.3 Egypt Opioid Use Disorder Consumption Forecast (2022-2028)
-
13.7.4 Algeria Opioid Use Disorder Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Opioid Use Disorder Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Opioid Use Disorder Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Opioid Use Disorder
-
Figure of Opioid Use Disorder Picture
-
Table Global Opioid Use Disorder Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Opioid Use Disorder Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global Buprenorphine Consumption and Growth Rate (2017-2022)
-
Figure Global Methadone Consumption and Growth Rate (2017-2022)
-
Figure Global Naltrexone Consumption and Growth Rate (2017-2022)
-
Figure Global Moderate Pain Treatment Consumption and Growth Rate (2017-2022)
-
Figure Global Severe Pain Treatment Consumption and Growth Rate (2017-2022)
-
Figure Global Opioid Use Disorder Consumption by Country (2017-2022)
-
Table North America Opioid Use Disorder Consumption by Country (2017-2022)
-
Figure United States Opioid Use Disorder Consumption and Growth Rate (2017-2022)
-
Figure Canada Opioid Use Disorder Consumption and Growth Rate (2017-2022)
-
Figure Mexico Opioid Use Disorder Consumption and Growth Rate (2017-2022)
-
Table Europe Opioid Use Disorder Consumption by Country (2017-2022)
-
Figure Germany Opioid Use Disorder Consumption and Growth Rate (2017-2022)
-
Figure UK Opioid Use Disorder Consumption and Growth Rate (2017-2022)
-
Figure Spain Opioid Use Disorder Consumption and Growth Rate (2017-2022)
-
Figure Belgium Opioid Use Disorder Consumption and Growth Rate (2017-2022)
-
Figure France Opioid Use Disorder Consumption and Growth Rate (2017-2022)
-
Figure Italy Opioid Use Disorder Consumption and Growth Rate (2017-2022)
-
Figure Denmark Opioid Use Disorder Consumption and Growth Rate (2017-2022)
-
Figure Finland Opioid Use Disorder Consumption and Growth Rate (2017-2022)
-
Figure Norway Opioid Use Disorder Consumption and Growth Rate (2017-2022)
-
Figure Sweden Opioid Use Disorder Consumption and Growth Rate (2017-2022)
-
Figure Poland Opioid Use Disorder Consumption and Growth Rate (2017-2022)
-
Figure Russia Opioid Use Disorder Consumption and Growth Rate (2017-2022)
-
Figure Turkey Opioid Use Disorder Consumption and Growth Rate (2017-2022)
-
Table APAC Opioid Use Disorder Consumption by Country (2017-2022)
-
Figure China Opioid Use Disorder Consumption and Growth Rate (2017-2022)
-
Figure Japan Opioid Use Disorder Consumption and Growth Rate (2017-2022)
-
Figure India Opioid Use Disorder Consumption and Growth Rate (2017-2022)
-
Figure South Korea Opioid Use Disorder Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Opioid Use Disorder Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Opioid Use Disorder Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Opioid Use Disorder Consumption and Growth Rate (2017-2022)
-
Figure Thailand Opioid Use Disorder Consumption and Growth Rate (2017-2022)
-
Figure Singapore Opioid Use Disorder Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Opioid Use Disorder Consumption and Growth Rate (2017-2022)
-
Figure Philippines Opioid Use Disorder Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Opioid Use Disorder Consumption and Growth Rate (2017-2022)
-
Table South America Opioid Use Disorder Consumption by Country (2017-2022)
-
Figure Brazil Opioid Use Disorder Consumption and Growth Rate (2017-2022)
-
Figure Colombia Opioid Use Disorder Consumption and Growth Rate (2017-2022)
-
Figure Chile Opioid Use Disorder Consumption and Growth Rate (2017-2022)
-
Figure Argentina Opioid Use Disorder Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Opioid Use Disorder Consumption and Growth Rate (2017-2022)
-
Figure Peru Opioid Use Disorder Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Opioid Use Disorder Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Opioid Use Disorder Consumption and Growth Rate (2017-2022)
-
Table GCC Opioid Use Disorder Consumption by Country (2017-2022)
-
Figure Bahrain Opioid Use Disorder Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Opioid Use Disorder Consumption and Growth Rate (2017-2022)
-
Figure Oman Opioid Use Disorder Consumption and Growth Rate (2017-2022)
-
Figure Qatar Opioid Use Disorder Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Opioid Use Disorder Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Opioid Use Disorder Consumption and Growth Rate (2017-2022)
-
Table Africa Opioid Use Disorder Consumption by Country (2017-2022)
-
Figure Nigeria Opioid Use Disorder Consumption and Growth Rate (2017-2022)
-
Figure South Africa Opioid Use Disorder Consumption and Growth Rate (2017-2022)
-
Figure Egypt Opioid Use Disorder Consumption and Growth Rate (2017-2022)
-
Figure Algeria Opioid Use Disorder Consumption and Growth Rate (2017-2022)
-
Table Oceania Opioid Use Disorder Consumption by Country (2017-2022)
-
Figure Australia Opioid Use Disorder Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Opioid Use Disorder Consumption and Growth Rate (2017-2022)
-
Table Alkermes Company Details
-
Table Alkermes Opioid Use Disorder Sales, Price, Value and Gross Profit (2017-2022)
-
Table Alkermes Opioid Use Disorder Main Business and Markets Served
-
Table Alkermes Opioid Use Disorder Product Portfolio
-
Table Omeros Company Details
-
Table Omeros Opioid Use Disorder Sales, Price, Value and Gross Profit (2017-2022)
-
Table Omeros Opioid Use Disorder Main Business and Markets Served
-
Table Omeros Opioid Use Disorder Product Portfolio
-
Table Orexo Company Details
-
Table Orexo Opioid Use Disorder Sales, Price, Value and Gross Profit (2017-2022)
-
Table Orexo Opioid Use Disorder Main Business and Markets Served
-
Table Orexo Opioid Use Disorder Product Portfolio
-
Table Titan Pharmaceuticals Company Details
-
Table Titan Pharmaceuticals Opioid Use Disorder Sales, Price, Value and Gross Profit (2017-2022)
-
Table Titan Pharmaceuticals Opioid Use Disorder Main Business and Markets Served
-
Table Titan Pharmaceuticals Opioid Use Disorder Product Portfolio
-
Table MediciNova Company Details
-
Table MediciNova Opioid Use Disorder Sales, Price, Value and Gross Profit (2017-2022)
-
Table MediciNova Opioid Use Disorder Main Business and Markets Served
-
Table MediciNova Opioid Use Disorder Product Portfolio
-
Table Teva Pharmaceuticals Company Details
-
Table Teva Pharmaceuticals Opioid Use Disorder Sales, Price, Value and Gross Profit (2017-2022)
-
Table Teva Pharmaceuticals Opioid Use Disorder Main Business and Markets Served
-
Table Teva Pharmaceuticals Opioid Use Disorder Product Portfolio
-
Table Hikma Pharmaceuticals Company Details
-
Table Hikma Pharmaceuticals Opioid Use Disorder Sales, Price, Value and Gross Profit (2017-2022)
-
Table Hikma Pharmaceuticals Opioid Use Disorder Main Business and Markets Served
-
Table Hikma Pharmaceuticals Opioid Use Disorder Product Portfolio
-
Table Camurus Company Details
-
Table Camurus Opioid Use Disorder Sales, Price, Value and Gross Profit (2017-2022)
-
Table Camurus Opioid Use Disorder Main Business and Markets Served
-
Table Camurus Opioid Use Disorder Product Portfolio
-
Table Indivior Company Details
-
Table Indivior Opioid Use Disorder Sales, Price, Value and Gross Profit (2017-2022)
-
Table Indivior Opioid Use Disorder Main Business and Markets Served
-
Table Indivior Opioid Use Disorder Product Portfolio
-
Figure Global Buprenorphine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Methadone Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Naltrexone Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Moderate Pain Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Severe Pain Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Opioid Use Disorder Consumption Forecast by Country (2022-2028)
-
Table North America Opioid Use Disorder Consumption Forecast by Country (2022-2028)
-
Figure United States Opioid Use Disorder Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Opioid Use Disorder Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Opioid Use Disorder Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Opioid Use Disorder Consumption Forecast by Country (2022-2028)
-
Figure Germany Opioid Use Disorder Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Opioid Use Disorder Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Opioid Use Disorder Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Opioid Use Disorder Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Opioid Use Disorder Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Opioid Use Disorder Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Opioid Use Disorder Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Opioid Use Disorder Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Opioid Use Disorder Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Opioid Use Disorder Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Opioid Use Disorder Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Opioid Use Disorder Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Opioid Use Disorder Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Opioid Use Disorder Consumption Forecast by Country (2022-2028)
-
Figure China Opioid Use Disorder Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Opioid Use Disorder Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Opioid Use Disorder Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Opioid Use Disorder Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Opioid Use Disorder Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Opioid Use Disorder Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Opioid Use Disorder Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Opioid Use Disorder Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Opioid Use Disorder Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Opioid Use Disorder Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Opioid Use Disorder Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Opioid Use Disorder Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Opioid Use Disorder Consumption Forecast by Country (2022-2028)
-
Figure Brazil Opioid Use Disorder Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Opioid Use Disorder Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Opioid Use Disorder Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Opioid Use Disorder Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Opioid Use Disorder Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Opioid Use Disorder Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Opioid Use Disorder Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Opioid Use Disorder Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Opioid Use Disorder Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Opioid Use Disorder Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Opioid Use Disorder Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Opioid Use Disorder Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Opioid Use Disorder Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Opioid Use Disorder Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Opioid Use Disorder Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Opioid Use Disorder Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Opioid Use Disorder Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Opioid Use Disorder Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Opioid Use Disorder Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Opioid Use Disorder Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Opioid Use Disorder Consumption Forecast by Country (2022-2028)
-
Figure Australia Opioid Use Disorder Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Opioid Use Disorder Consumption Forecast and Growth Rate (2022-2028)
-
